Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Physician benefit-risk preferences for non-metastatic castration-resistant prostate cancer treatment (nmCRPC). Srinivas, S., Mohamed, A. F., Appukkuttan, S., Botteman, M., Ng, X., Joshi, N., Horodniceanu, E., Waldeck, R., Simmons, S. J. AMER SOC CLINICAL ONCOLOGY. 2019
View details for DOI 10.1200/JCO.2019.37.15_suppl.e16610
View details for Web of Science ID 000487345801626